Scarica l'app Stockscreener
102.77
0.15%
0.13
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$102.64
Aprire:
$102.8
Volume 24 ore:
3.45M
Relative Volume:
0.48
Capitalizzazione di mercato:
$152.25B
Reddito:
$18.49B
Utile/perdita netta:
$2.51B
Rapporto P/E:
61.17
EPS:
1.68
Flusso di cassa netto:
$3.23B
1 W Prestazione:
-0.15%
1M Prestazione:
-0.39%
6M Prestazione:
-3.15%
1 anno Prestazione:
+35.40%
Intervallo 1D:
$101.62
$103.07
Intervallo di 1 settimana:
$101.62
$104.46
Portata 52W:
$75.53
$108.53
Boston Scientific Corp Stock (BSX) Company Profile
Nome
Boston Scientific Corp
Settore
Industria
Telefono
508-683-4000
Indirizzo
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Confronta BSX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
102.75 | 152.25B | 18.49B | 2.51B | 3.23B | 1.68 |
|
ABT
Abbott Laboratories
|
129.10 | 228.63B | 43.11B | 13.98B | 6.78B | 7.98 |
|
SYK
Stryker Corp
|
378.11 | 144.00B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.96 | 118.82B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.87 | 45.89B | 5.69B | 4.14B | 577.90M | 6.96 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-16 | Iniziato | Leerink Partners | Outperform |
| 2025-04-16 | Aggiornamento | Needham | Hold → Buy |
| 2025-01-10 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-10-18 | Downgrade | Needham | Buy → Hold |
| 2024-05-30 | Iniziato | Goldman | Buy |
| 2024-02-01 | Aggiornamento | Mizuho | Neutral → Buy |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2023-06-30 | Iniziato | CL King | Buy |
| 2023-05-30 | Ripresa | Morgan Stanley | Overweight |
| 2023-03-29 | Iniziato | UBS | Buy |
| 2022-12-22 | Iniziato | Mizuho | Neutral |
| 2022-12-20 | Ripresa | Citigroup | Buy |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-07-06 | Iniziato | Wolfe Research | Outperform |
| 2022-05-27 | Aggiornamento | Needham | Hold → Buy |
| 2022-04-13 | Ripresa | Truist | Buy |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-05-26 | Downgrade | Needham | Buy → Hold |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-15 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-17 | Iniziato | Truist | Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Peer Perform |
| 2020-04-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Neutral |
| 2020-02-06 | Ripresa | BTIG Research | Buy |
| 2019-12-30 | Reiterato | Cowen | Outperform |
| 2019-12-19 | Downgrade | Needham | Strong Buy → Buy |
| 2019-09-05 | Ripresa | JP Morgan | Overweight |
| 2019-09-03 | Ripresa | Barclays | Overweight |
| 2019-05-13 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2018-11-28 | Iniziato | UBS | Buy |
| 2018-10-16 | Iniziato | Barclays | Overweight |
| 2018-10-02 | Reiterato | Morgan Stanley | Overweight |
| 2018-09-07 | Reiterato | Needham | Strong Buy |
| 2018-09-04 | Aggiornamento | Jefferies | Hold → Buy |
| 2018-07-06 | Reiterato | Needham | Strong Buy |
| 2018-06-27 | Iniziato | Bernstein | Outperform |
| 2018-04-26 | Reiterato | Needham | Strong Buy |
Mostra tutto
Boston Scientific Corp Borsa (BSX) Ultime notizie
Structural Heart Devices Market Set to Expand and Reach ~USD 25 Billion by 2032 Amid Rising Demand for Minimally Invasive Solutions | DelveInsight - GlobeNewswire Inc.
Are Medical Stocks Lagging Boston Scientific (BSX) This Year? - Yahoo Finance
Fund Update: FLPUTNAM INVESTMENT MANAGEMENT CO added 95,234 shares of BOSTON SCIENTIFIC ($BSX) to their portfolio - Quiver Quantitative
3 Reasons Growth Investors Will Love Boston Scientific (BSX) - Yahoo Finance
Boston Scientific Corporation Is Expensive But Worth It - Seeking Alpha
Boston Scientific (NYSE:BSX) Is Experiencing Growth In Returns On Capital - ca.finance.yahoo.com
Boston Scientific updates instructions of devices linked to 17 deaths - MedTech Dive
Boston Scientific Reports 16 Deaths Linked To Defibrillator Lead Issue - Yahoo Finance
FDA says Watchman access alert remedied by review of IFU - BioWorld MedTech
FDA issues alert for updated instructions for certain Boston Scientific Watchman access systems - MassDevice
FDA flags problems with two Boston Scientific heart devices tied to injuries and deaths - MSN
Q2 Medical Devices & SuppliesDiversified Earnings: Boston Scientific (NYSE:BSX) Earns Top Marks - ca.finance.yahoo.com
Boston Scientific tells users about defibrillator problem linked to deaths, injuries - MedTech Dive
Oppenheimer Lifts Boston Scientific (BSX) PT to $118 Following Strong Q2 Results - Insider Monkey
Investors Heavily Search Boston Scientific Corporation (BSX): Here is What You Need to Know - Yahoo Finance
Boston Scientific survey reveals weight loss struggles among women, launches Endura procedures - MassDevice
Boston Scientific stock falls after FDA discloses defibrillation lead issue - Investing.com
Former FDA Director and Boston Scientific Leaders Join Keyron Ahead of Human Trials of First Device with Metabolic Surgery-Like Results Without Incisions - Yahoo Finance
CMCT Announces 30,821-Square-Foot Lease to Boston Scientific Corporation at Penn Field, a 228,000-Square-Foot Creative Office Campus in Austin - The Globe and Mail
BSX Stock Quote Price and Forecast - CNN
Boston Scientific Corporation Could See a Relief Rally From SupportDaily Growth Stock Pick Reports Show Bullish Signals - metal.it
Investing in Boston Scientific (NYSE:BSX) Five Years Ago Would Have Delivered You a 170% Gain - 富途牛牛
Boston Scientific Second Quarter 2025 Earnings: Beats Expectations - ca.finance.yahoo.com
BOSTON SCIENTIFIC CORPORATION (BSX) - MSN
Boston Scientific Stock Outlook: Is Wall Street Bullish or Bearish? - MSN
Oppenheimer Adjusts Boston Scientific (BSX) Price Target After Q - GuruFocus
What are the latest earnings results for Boston Scientific CorporationCapitalize on emerging investment opportunities - Jammu Links News
What are Boston Scientific Corporation company’s key revenue driversMarket-beating returns - Jammu Links News
Truist Boosts Boston Scientific (BSX) Price Target After Strong Quarter - Insider Monkey
Chart Analysts Warn of Resistance Near Boston Scientific Corporation PriceGrowth Based Investment Plan Guidance Highlighted - metal.it
Boston Scientific earns Medicare reimbursement for Agent drug-coated balloon - MassDevice
Is It Worth Investing in Boston Scientific (BSX) Based on Wall Street's Bullish Views? - Yahoo Finance
Boston Scientific Stock Outlook: Is Wall Street Bullish Or Bearish? - Barchart.com
BOSTON SCIENTIFIC CORP SEC 10-Q Report - TradingView
Boston Scientific Director Fujimori Sells $310,377 Worth of Stock - AInvest
11 Best Medical Stocks to Buy According to Analysts - Insider Monkey
Boston Scientific warns of shock impedance with certain defibrillator leads - MassDevice
Boston Sci offers new neuromod treatments to European patients - BioWorld MedTech
Boston Scientific Corporation Reversal Rally May Surprise BearsOversold Bounce Stock Play Ideas Gain Attention - metal.it
Boston Scientific Corp Azioni (BSX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.33%
1.28%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):